• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
India In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012 Product Image

India In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

  • Published: October 2008
  • Region: India
  • 117 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • ATNT Laboratories
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • Embee Diagnostics
  • Gen-Probe Incorporated
  • MORE

India In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the India In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the In vitro diagnostic dvices in India

Scope

- The report provides in vitro diagnostics information broken down into detailed categories and segments in India.
- Total revenues, end users
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, READ MORE >

1 2
1.1 List of Tables 9
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of markets covered in the report 14
3.1 In Vitro Diagnostics 14
3.2 Clinical Biochemistry Test Reagents 14
3.3 Immunochemistry Test Reagents 14
3.3.1 Disease Specific Markers 14
3.3.2 Disease Specific Test Reagents 14
3.3.3 Drug Related Testing Reagents 15
3.3.4 Hormone Related Testing Reagents 15
3.3.5 Immunohistochemistry 15
3.4 Hematology & Histopathology Test Reagents 16
3.4.1 Hematology Test Reagents 16
3.4.2 Histopathology Reagents 16
3.5 Microbiology Test Reagents 17
3.5.1 Bacteriology Test Reagents 17
3.6 Infectious Immunology Test Reagents 17
3.6.1 Virology Test Reagents 17
3.6.2 Parasitology Tests Reagents 17
3.7 Instruments 17
3.8 Rapid Tests 17
3.8.1 Infectious Immunology Rapid Tests 18
3.8.2 Microbiology Rapid Tests 18
3.8.3 Immunochemistry Rapid Tests 18
3.8.4 Clinical Chemistry Rapid Tests 18
4 Healthcare Sector Review 19
4.1 Healthcare Expenditure 19
4.2 Healthcare Infrastructure 21
4.2.1 Healthcare Infrastructure (2007) 22
4.3 Healthcare Policy 23
5 Regulation System 24
5.1 Medical Equipment Approval 24
5.2 Central Drugs Authority of India (CDAI) 25
5.3 Medical Device Regulatory Authority of India (MDRAI) 25
5.4 Classification of Medical Devices 25
5.4.1 Registration Period 26
6 Pricing and Reimbursement 27
6.1 Pricing and Reimbursement 27
7 Distribution Structure 28
7.1 Distribution Structure 28
8 In Vitro Diagnostics in India 29
8.1 In Vitro Diagnostics Overall Revenues by Category (2000-2012) 29
9 Instruments in India 32
9.1 Instruments Revenues (2000-2012) 32
9.2 Instruments Distribution Share (2006-2007) 34
9.3 Instruments Company Share (2006-2007) 35
10 Immunochemistry Test Reagents in India 36
10.1 Immunochemistry Test Reagents Revenues by Segment (2000-2012) 36
10.1.1 Disease Specific Test Reagents Revenues by Sub-Segment (2000-2012) 38
10.1.2 Hormone Related Testing Reagents Revenues by Sub-Segment (2000-2012) 40
10.1.3 Immunohistochemistry Test Reagents Revenues by Sub-Segment (2000-2012) 42
10.2 Immunochemistry Test Reagents Distribution Share (2006-2007) 44
10.3 Immunochemistry Test Reagents Company Share (2006-2007) 45
11 Clinical Biochemistry Test Reagents in India 46
11.1 Clinical Biochemistry Test Reagents Revenues (2000-2012) 46
11.2 Clinical Biochemistry Test Reagents Distribution Share (2006-2007) 48
11.3 Clinical Biochemistry Test Reagents Company Share (2006-2007) 49
12 Haematology & Histopathology Test Reagents in India 50
12.1 Haematology & Histopathology Test Reagents Revenues by Segment (2000-2012) 50
12.1.1 Haematology Test Reagents Revenues by Sub-Segment (2000-2012) 52
12.1.2 Histopathology Reagents Revenues by Sub-Segment (2000-2012) 54
12.2 Haematology & Histopathology Test Reagents Distribution Share (2006-2007) 56
12.3 Haematology & Histopathology Test Reagents Company Share (2006-2007) 57
13 Rapid Test Reagents in India 58
13.1 Rapid Tests Revenues by Segment (2000-2012) 58
13.2 Rapid Tests Distribution Share (2006-2007) 60
13.3 Rapid Tests Company Share (2006-2007) 61
14 Infectious Immunology Test Reagents in India 62
14.1 Infectious Immunology Test Reagents Revenues by Segment (2000-2012) 62
14.2 Infectious Immunology Test Reagents Distribution Share (2006-2007) 64
14.3 Infectious Immunology Test Reagents Company Share (2006-2007) 65
15 Microbiology Test Reagents in India 66
15.1 Microbiology Test Reagents Revenues (2000-2012) 66
15.2 Microbiology Test Reagents Distribution Share (2006-2007) 68
15.3 Microbiology Test Reagents Company Share (2006-2007) 69
16 Abbott Laboratories Company Profile 70
16.1 Company Overview 70
16.2 Value Chain Analysis 70
16.2.1 Manufacturing 71
16.2.2 Product Development 71
16.2.3 Sales and Marketing 72
17 Beckman Coulter, Inc. Company Profile 73
17.1 Company Overview 73
17.2 Value Chain Analysis 73
17.2.1 Manufacturing 74
17.2.2 Product Development 74
17.2.3 Sales and Marketing 74
17.3 Beckman Coulter, Inc. Pipeline Products 75
17.3.1 Beckman Coulter, Inc. Pipeline Products by Equipment Type 75
17.3.2 Beckman Coulter, Inc. Pipeline Products by Development Stage 76
17.3.3 Beckman Coulter, Inc. Pipeline Products by Therapy Area 77
17.3.4 Beckman Coulter, Inc. Pipeline Products by News Summary 77
18 bioMerieux S.A. Company Profile 78
18.1 Company Overview 78
18.2 Value Chain Analysis 78
18.2.1 Manufacturing 79
18.2.2 Product Development 79
18.2.3 Sales and Marketing 80
19 Siemens Medical Solutions 81
19.1 Company Overview 81
19.1.1 Industry Outlook - Diagnostic Imaging 81
19.2 Value Chain Analysis 82
19.2.1 Manufacturing 82
19.2.2 Product Development 83
19.2.3 Sales and Marketing 83
20 Roche Diagnostics Limited Company Review 84
20.1 Company Overview 84
20.2 Roche Diagnostics Limited Pipeline Products 84
20.2.1 Roche Diagnostics Limited Pipeline Products by Equipment Type 84
20.2.2 Roche Diagnostics Limited Pipeline Products by Development Stage 86
20.2.3 Roche Diagnostics Limited Pipeline Products by Therapy Area 87
20.2.4 Roche Diagnostics Limited Pipeline Products by Clinical Trials 87
20.2.5 Roche Diagnostics Limited Pipeline Products by News Summary 88
21 J.Mitra & Co. Ltd. Company Review 89
21.1 Company Overview 89
22 Span Diagnostics Limited Company Review 90
22.1 Company Overview 90
23 Ortho-Clinical Diagnostics Inc. Company Review 91
23.1 Company Overview 91
24 Gen-Probe Incorporated Company Profile 92
24.1 Company Overview 92
24.2 Value Chain Analysis 92
24.2.1 Manufacturing 93
24.2.2 Product Development 93
24.2.3 Sales and Marketing 94
24.3 Gen-Probe Incorporated Pipeline Products 94
24.3.1 Gen-Probe Incorporated Pipeline Products by Equipment Type 94
24.3.2 Gen-Probe Incorporated Pipeline Products by Development Stage 96
24.3.3 Gen-Probe Incorporated Pipeline Products by Therapy Area 97
24.3.4 Gen-Probe Incorporated Pipeline Products by Clinical Trials 97
24.3.5 Gen-Probe Incorporated Pipeline Products by News Summary 98
25 Becton, Dickinson and Company Profile 99
25.1 Company Overview 99
25.2 Value Chain Analysis 99
25.2.1 Manufacturing 100
25.2.2 Product Development 100
25.2.3 Sales and Marketing 100
26 Transasia Bio-Medicals Ltd. Company Profile 101
26.1 Company Overview 101
27 Accurex Biomedical Pvt. Ltd. Company Review 102
27.1 Company Overview 102
28 Bhat Bio-tech India (P)Ltd Company Review 103
28.1 Company Overview 103
29 ATNT Laboratories Company Review 104
29.1 Company Overview 104
30 Embee Diagnostics Company Review 105
30.1 Company Overview 105
31 ST Corporation Company Review 106
31.1 Company Overview 106
32 Financial Deals Landscape 107
32.1 Merger 107
32.1.1 Canere Actives & Fine Chemicals Merges With Nicholas Piramal India 107
32.1.2 DxTech Enters Into Partnership With Nicholas Piramal India 108
32.1.3 Transasia Bio-Medicals Signs Agreement With Grifols 110
33 Appendix 112
33.1 Global Markets Direct Research Methodology 112
33.2 Coverage 113
33.3 Secondary Research 113
33.4 Primary Research 114
33.5 Models 114
33.6 Forecasts 115
33.7 Expert Panels 115
33.8 Currency Conversion 116
33.9 Contact Us 117
33.10 Disclaimer 117

Executive Summary

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in India, 2000-2006 20
Figure 2: Healthcare Expenditure in India by Source, 2006 21
Figure 3: Proposed Medical Equipment Classification in India, 2005 26
Figure 4: In Vitro Diagnostics, India, Category Revenues ($ mn), 2000-2012 29
Figure 5: In Vitro Diagnostics, India, Category Revenues ($ mn), Historic, 2000-2007 30
Figure 6: In Vitro Diagnostics, India, Category Revenues ($ mn), Forecast, 2007-2012 31
Figure 7: Instruments, India, Revenue ($ mn), Historic, 2000-2007 32
Figure 8: Instruments, India, Revenue ($ mn), Forecast, 2007-2012 33
Figure 9: Instruments, India, Company Share (%), 2007 35
Figure 10: Immunochemistry Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2007 36
Figure 11: Immunochemistry Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2007-2012 37
Figure 12: Disease Specific Test Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007 38
Figure 13: Disease Specific Test Reagents, India, Revenue ($ mn) by Sub-segment, Forecast, 2007-2012 39
Figure 14: Hormone Related Testing Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007 40
Figure 15: Hormone Related Testing Reagents, India, Revenue ($ mn) by Sub-segment, Forecast, 2007-2012 41
Figure 16: Immunohistochemistry Test Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007 42
Figure 17: Immunohistochemistry Test Reagents, India, Revenue ($ mn) by Sub-segment, Forecast, 2007-2012 43
Figure 18: Immunochemistry Test Reagents, India, Company Share (%), 2007 45
Figure 19: Clinical Biochemistry Test Reagents, India, Revenue ($ mn), Historic, 2000-2007 46
Figure 20: Clinical Biochemistry Test Reagents, India, Revenue ($ mn), Forecast, 2007-2012 47
Figure 21: Clinical Biochemistry Test Reagents, India, Company Share (%), 2007 49
Figure 22: Haematology & Histopathology Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2007 50
Figure 23: Haematology & Histopathology Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2007-2012 51
Figure 24: Haematology Test Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007 52
Figure 25: Haematology Test Reagents, India, Revenue ($ mn) by Sub-segment, Forecast, 2007-2012 53
Figure 26: Histopathology Reagents, India, Revenue ($ mn) by Sub-segment, Historic, 2000-2007 54
Figure 27: Histopathology Reagents, India, Revenue ($ mn) by Sub-segment, Forecast, 2007-2012 55
Figure 28: Haematology & Histopathology Test Reagents, India, Company Share (%), 2007 57
Figure 29: Rapid Tests, India, Revenue ($ mn) by Segment, Historic, 2000-2007 58
Figure 30: Rapid Tests, India, Revenue ($ mn) by Segment, Forecast, 2007-2012 59
Figure 31: Rapid Tests, India, Company Share (%), 2006 61
Figure 32: Infectious Immunology Test Reagents, India, Revenue ($ mn) by Segment, Historic, 2000-2007 62
Figure 33: Infectious Immunology Test Reagents, India, Revenue ($ mn) by Segment, Forecast, 2007-2012 63
Figure 34: Infectious Immunology Test Reagents, India, Company Share (%), 2007 65
Figure 35: Microbiology Test Reagents, India, Revenue ($ mn), Historic, 2000-2007 66
Figure 36: Microbiology Test Reagents, India, Revenue ($ mn), Forecast, 2007-2012 67
Figure 37: Microbiology Test Reagents, India, Company Share (%), 2007 69
Figure 38: Abbott Laboratories, Value Chain Analysis 70
Figure 39: Beckman Coulter, Inc., Value Chain Analysis 73
Figure 40: bioMerieux S.A., Value Chain Analysis 78
Figure 41: Siemens Medical Solutions, Value Chain Analysis 82
Figure 42: Roche Diagnostics Limited Pipeline Products By Equipment Type 84
Figure 43: Roche Diagnostics Limited Pipeline Products By Equipment Type 85
Figure 44: Roche Diagnostics Limited Pipeline Products By Development Stage 86
Figure 45: Roche Diagnostics Limited Pipeline Products By News Summary 88
Figure 46: Gen-Probe Incorporated, Value Chain Analysis 92
Figure 47: Gen-Probe Incorporated Pipeline Products By Equipment Type 94
Figure 48: Gen-Probe Incorporated Pipeline Products By Equipment Type 95
Figure 49: Gen-Probe Incorporated Pipeline Products By Development Stage 96
Figure 50: Gen-Probe Incorporated Pipeline Products By News Summary 98
Figure 51: Becton, Dickinson and Company, Value Chain Analysis 99
Figure 52: Global Markets Direct Methodology 112

Abbott Laboratories
Beckman Coulter, Inc.
bioMerieux S.A.
Siemens Medical
Roche Diagnostics Limited
J.Mitra & Co. Ltd.
Span Diagnostics Limited
Ortho-Clinical Diagnostics Inc.
Gen-Probe Incorporated
Becton, Dickinson and Company
Transasia Bio-Medicals Ltd.
Accurex Biomedical Pvt. Ltd.
Bhat Bio-tech India (P)Ltd
ATNT Laboratories
Embee Diagnostics
ST Corporation

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos